Frederik Marmé
Werke:
- A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
- ABC3 Consensus Commented from the Perspective of the German Guidelines : Third International Consensus Conference for Advanced Breast Cancer (ABC3), Lisbon, 07. 11. 2015
- Subgroup analysis of patients with HER2-negative metastatic breast cancer in the second-line setting from a phase 3, open-label, randomized study of eribulin mesilate versus capecitabine
- Antikörper-Wirkstoff-Konjugate in der gynäkologischen Onkologie